1. Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy.
- Author
-
Tang S, Wang W, Wang Y, Gao Y, Dai K, Zhang W, Wu X, Yuan X, Jin C, Zan X, Zhu L, and Geng W
- Subjects
- Animals, Mice, NADH, NADPH Oxidoreductases metabolism, Mice, Inbred C57BL, Colitis, Ulcerative drug therapy, Colitis, Ulcerative metabolism, Male, Prodrugs chemistry, Prodrugs pharmacokinetics, Mesalamine chemistry, Mesalamine pharmacokinetics, Nitroreductases metabolism, Colon metabolism, Colon pathology, Polymers chemistry, Micelles, Colitis drug therapy, Colitis metabolism, Delayed-Action Preparations chemistry
- Abstract
Ulcerative colitis (UC) is a challenging inflammatory gastrointestinal disorder, whose therapies encounter limitations in overcoming insufficient colonic retention and rapid systemic clearance. In this study, we report an innovative polymeric prodrug nanoformulation for targeted UC treatment through sustained 5-aminosalicylic acid (5-ASA) delivery. Amphiphilic polymer-based 13.5 nm micelles were engineered to incorporate azo-linked 5-ASA prodrug motifs, enabling cleavage via colonic azoreductases. In vitro, micelles exhibited excellent stability under gastric/intestinal conditions while demonstrating controlled 5-ASA release over 24 h in colonic fluids. Orally administered micelles revealed prolonged 24-h retention and a high accumulation within inflamed murine colonic tissue. At an approximately 60% dose reduction from those most advanced recent studies, the platform halted DSS colitis progression and outperformed standard 5-ASA therapy through a 77-97% suppression of inflammatory markers. Histological analysis confirmed intact colon morphology and restored barrier protein expression. This integrated prodrug nanoformulation addresses limitations in colon-targeted UC therapy through localized bioactivation and tailored pharmacokinetics, suggesting the potential of nanotechnology-guided precision delivery to transform disease management., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF